Yahoo Αναζήτηση Διαδυκτίου

Αποτελέσματα Αναζήτησης

1. www.medicoverhospitals.in › articles › scleroderma-treatmentTreating Scleroderma: Medications, Therapy & Alternative Options

   www.medicoverhospitals.in › articles › scleroderma-treatment

   • Αποθηκευμένο αντίγραφο

   1 ημέρα πριν · Here are some tips for managing skin symptoms: Moisturize regularly : Use thick, fragrance-free moisturizers to keep the skin hydrated. Avoid hot showers : Hot water can dry out the skin, so opt for lukewarm showers instead. Protect your skin : Use sunscreen and protective clothing to shield your skin from the sun.

2. radiopaedia.org › articles › scleroderma-musculoskeletal-manifestations-1Scleroderma (musculoskeletal manifestations) - Radiopaedia.org

   radiopaedia.org › articles › scleroderma-musculoskeletal-manifestations-1

   • Αποθηκευμένο αντίγραφο

   6 Ιουλ 2024 · Symptomatic joints are present in ~40% (range 12-65%) of patients when diagnosed and overall are present in ~60% (range 24-97%) of patients at sometime during their illness course 6,8. Clinical presentation. Musculoskeletal presentations of scleroderma stiffness, pain, reduced dexterity, reduced power, which is often multifactorial in etiology 6-8:

3. scleroderma.orgNational Scleroderma Foundation

   scleroderma.org

   5 ημέρες πριν · Find Your Best Path. Where to Start. More than 300,000 Americans live with some type of scleroderma. Today, the face of scleroderma includes people of all ages, genders, and backgrounds. Scleroderma can affect young parents, children, grandparents, and teenagers.

4. www.ajnr.org › ajnr-case-collections-diagnosis › linear-sclerodermaLinear Scleroderma | American Journal of Neuroradiology

   www.ajnr.org › ajnr-case-collections-diagnosis › linear-scleroderma

   • Αποθηκευμένο αντίγραφο

   11 Ιουλ 2024 · Seizures are the most frequent symptom. Other symptoms include focal neurologic deficits and movement disorders, which can be secondary to brain lesions, trigeminal neuralgia, masticatory spasms, behavioral changes, or progressive intellectual deterioration due to cerebral hemiatrophy. Key Diagnostic Features:

5. www.medscape.org › viewarticle › 743160Scleroderma-Related PAH: The Need for Early Diagnosis and...

   www.medscape.org › viewarticle › 743160

   • Αποθηκευμένο αντίγραφο

   5 ημέρες πριν · Describe the clinical characteristics of scleroderma patients that place them at high risk of developing PAH. Devise strategies to optimize screening and early detection of PAH in scleroderma patients. Develop best management practices to improve the care of patients with scleroderma-related PAH.

6. www.scleroderma.org.au › news › promoting-cell-death-process-may-help-to-limitPromoting cell death process may help to limit skin fibrosis in...

   www.scleroderma.org.au › news › promoting-cell-death-process-may-help-to-limit

   • Αποθηκευμένο αντίγραφο

   9 Ιουλ 2024 · The study, “ Upregulation of GPX4 drives ferroptosis resistance in scleroderma skin fibroblasts,” was published in Free Radical Biology and Medicine. Skin fibrosis in SSc tied to excess of fibroblasts and collagen ... and current disease treatments aim to manage symptoms associated with scleroderma. No available therapies are specifically ...

7. www.jcvaonline.com › article › S1053-0770(24)00490-7Commentary: Scleroderma and Coronary Vasospasm after Cardiac...

   www.jcvaonline.com › article › S1053-0770(24)00490-7

   1 ημέρα πριν · Coronary vasospasm (CVS) is transient partial or complete occlusion of coronary artery resulting in a spectrum of coronary symptoms including rest chest pain, pain during minor activities, acute coronary syndrome (ACS) with or without electrocardiographic (EKG) changes or sudden cardiac death (SCD)1. In people presenting with myocardial infarction with no obstructive coronary arteries (MINOCA ...